Lupin Limited has informed the Exchange regarding a press release dated November 05, 2025, titled "Lupin Receives EIR from U.S. FDA for its Pithampur Unit-3 Facility".
Press Release Nov 05 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Lupin
- Press Release Oct 30 2025
- Press Release Oct 28 2025
- Governor Murphy and Local Leaders Attend Ribbon-Cutting Ceremony, Marking the Inauguration of Lupin's New Corporate Offices in Bridgewater
- Press Release Oct 24 2025
- Kenox Pharmaceuticals Appoints Dr. Julianne Berry as Vice President of R&D and Manufacturing
Later from Lupin
- Press Release Nov 06 2025
- Press Release Nov 08 2025
- Press Release Nov 12 2025
- Press Release Nov 13 2025
- Lupin Launches Risperidone Long-Acting Injectable with 180-day CGT exclusivity in the U.S., the First Product from its Proprietary Long-Acting Injectable Platform PrecisionSphere™
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin